BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23436256)

  • 1. Antipsychotic interventions in prodromal psychosis: safety issues.
    Liu CC; Demjaha A
    CNS Drugs; 2013 Mar; 27(3):197-205. PubMed ID: 23436256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is clinical intervention in the ultra high risk phase effective?
    McGuire P; Selvaraj S; Howes O
    Braz J Psychiatry; 2011 Oct; 33 Suppl 2():s161-74. PubMed ID: 22286566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
    Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
    J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis).
    Zhang T; Xu L; Tang X; Wei Y; Hu Q; Hu Y; Cui H; Tang Y; Hui L; Li C; Cao L; Lu Z; Wang J
    Aust N Z J Psychiatry; 2020 Jul; 54(7):696-706. PubMed ID: 32436725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics Do Not Influence Neurological Soft Signs in Children and Adolescents at Ultra-High Risk for Psychosis: A Pilot Study.
    Pitzianti M; Casarelli L; Pontillo M; Vicari S; Armando M; Pasini A
    J Psychiatr Pract; 2019 May; 25(3):186-191. PubMed ID: 31083030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness and feasibility of preventive interventions for psychoses].
    Dorofeikova MV; Petrova NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8):108-112. PubMed ID: 31626178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
    Bioque M; Llerena A; Cabrera B; Mezquida G; Lobo A; González-Pinto A; Díaz-Caneja CM; Corripio I; Aguilar EJ; Bulbena A; Castro-Fornieles J; Vieta E; Lafuente A; Mas S; Parellada M; Saiz-Ruiz J; Cuesta MJ; Bernardo M;
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26506856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research and practice for ultra-high risk for psychosis: A national survey of early intervention in psychosis services in England.
    Stain HJ; Mawn L; Common S; Pilton M; Thompson A
    Early Interv Psychiatry; 2019 Feb; 13(1):47-52. PubMed ID: 28612979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
    Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of remission from the ultra-high risk state for psychosis.
    Glenthøj LB; Kristensen TD; Wenneberg C; Hjorthøj C; Nordentoft M
    Early Interv Psychiatry; 2021 Feb; 15(1):104-112. PubMed ID: 31910496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for clinical interventions in prodromal psychosis. Are such interventions safe?
    Agius M; Butler S
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S28-35. PubMed ID: 22945183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample.
    Walker EF; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Heinssen R
    Schizophr Res; 2009 Nov; 115(1):50-7. PubMed ID: 19709859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.